Osteopontin siRNA does not confer resistance to toxic effects of parthenolide in Jurkat cells

Summary. Background: Osteopontin (OPN) plays a critical role in cell proliferation and drug resistance in cancer treatment and hematological malignancies. In T cell acute lymphoblastic leukemia, most initial therapies can induce remission while some patients then relapse and do not respond...

Full description

Saved in:
Bibliographic Details
Date:2023
Main Authors: Mehri, S., Mohammadi, S., Nikbakht, M., Sahmani, M., Zahedpanah, M.
Format: Article
Language:English
Published: PH Akademperiodyka 2023
Subjects:
Online Access:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-15
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Experimental Oncology

Institution

Experimental Oncology